Girawan D. Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss. InaJGHE [Internet]. 2026 Apr. 30 [cited 2026 Oct. 23];27(1):1-2. Available from: https://www.ina-jghe.com/index.php/jghe/article/view/1248